Found 84 matching trials
Iberoamerican Protocol With Thalidomide in Patients With Symptomatic Newly Diagnosed Multiple Myeloma Over 65 Years PHASE3 This protocol is an international, multicenter, comparative, open and rando...
Show More Location
Hospital Universitário Clementino Fraga Filho
Learn More & Join Trial
Combination Chemotherapy in Treating Patients With Multiple Myeloma PHASE3 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
St. Mary's/Duluth Clinic Health System
Learn More & Join Trial
Celgene High Risk Multiple Myeloma (MM) Revlimid Induction and Maintenance Therapy PHASE2 The purpose of this study is to evaluate the effectiveness of induction the...
Show More Location
Duke University Medical Center
Learn More & Join Trial
Bortezomib/Adriamycine/Melfalan/Prednisone (VAMP)/Thalidomide/Cyclophosphamide/Dexamethasone (TaCyDex) or Bortezomib/Melfalan/Prednisone (V-MP)/TaCyDex) in Refractary or Relapsed Multiple Myeloma PHASE4 Multicentric study, open, single arm, designed to evaluate the efficacy(res...
Show More Location
Hospital Morales Messeguer
Learn More & Join Trial
Velcade-Melphalan-Prednisone in Older Untreated Multiple Myeloma Patients. PHASE1 This protocol is planned as a multicentric, national, open-label trial desi...
Show More Learn More & Join Trial
STUDY COMPARING TWO STANDARD TREATMENTS IN AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE POPULATION AFFECTED BY MULTIPLE MYELOMA PHASE4 Multiple myeloma (MM) is a neoplastic disease deriving from an abnormal pro...
Show More Status
Active Not Recruiting
Location
Dipartimento di Biotecnologie Molecolari e Scienze per la Salute
Learn More & Join Trial
Rituximab in Addition to Chemotherapy With Autologous Stem Cell Transplantation as Treatment Diffuse Large B-Cell Lymphoma PHASE2 The purpose of this trial was to evaluate efficacy and safety of adding Rit...
Show More Location
Az. Ospedaliera SS. Antonio e Biagio e Cesare Arrigo
Learn More & Join Trial
Combination Chemotherapy With or Without High Dose Cyclophosphamide and Recombinant Interferon Alfa-2b in Treating Patients With Previously Untreated Stage I-III Multiple Myeloma PHASE3 This randomized phase III clinical trial studies combination chemotherapy w...
Show More Location
Eastern Cooperative Oncology Group
Learn More & Join Trial
Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma PHASE3 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
Leeds Teaching Hospital Trust
Learn More & Join Trial
Dasatinib in Combination With Melphalan and Prednisone to Treat Relapsed and Refractory Multiple Myeloma Patients PHASE2 Clinically demonstrated efficacy of Melphalan and Prednisone in MM subjects...
Show More Learn More & Join Trial